NAUT Nautilus Biotechnology, Inc.
NAUT Nautilus Biotechnology, Inc.
Healthcare · Biotechnology
Desk view
Market read
POC $1.93 · VWAP $1.84 · +12.2% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
NAUT Price Structure
Loading timeframes…
Peers
Every watchlist NAUT belongs to, members best 30-day change first — NAUT highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
Reported the quarter ending 2026-06-30: revenue $190000, diluted EPS -$0.11, net income -$14M (SEC filing). Across the print the stock moved -37.3% (close before → first close after).
full note →Against street estimates
How NAUT's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about NAUT from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 8 days ago · Oct 9
- Nautilus Biotechnology Inc. (NAUT) Stock Price | Live Quotes & Charts | NASDAQ
- naut-20260911 - SEC.gov
- naut-20260728
- Nautilus Biotechnology | Science Company | Labroots
- Financial News | myMotherLode.com - Nautilus Biotechnology, Inc. - Common Stock (Nasdaq:NAUT) Stock Quote
- Stock Quote & Chart | Nautilus Biotechnology Inc.
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
NAUT research tape
19 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.